Methyl 6-bromo-5-methylpyrazine-2-carboxylate, 97.0%, 250mg

(R)-4-Benzyl-5-oxomorpholine-3-carboxylic acid, 95.0%, 100g

Methyl 4-bromo-5-fluoropicolinate, 95%, 250mg

N-methyl-N-[4-(methylsulfonyl)-1,3-benzothiazol-2-yl]glycine, 95.0%, 500mg

2-Bromo-6-nitropyridin-3-ol, 98%, 250mg

Fucsina básica (CI 42510), 100 g

2',4'-Difluoroacetophenone, 98.0%, 50g

5-Pyrimidinecarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-3-fluorophenyl]-3-(4-fluorophenyl)-1,2,3,4-tetrahydro-1-(1-methylethyl)-2,4-dioxo-, 98%, 100mg

3-Tetrazol-1-yl-benzoic acid, 95.0%, 250mg

Nonacosanoic Acid>95.0%(GC)1g

1-(4-Bromophenyl)-7,8-dimethoxy-4-methyl-4,5-dihydro-3H-benzo[d][1,2]diazepine, 97%, 100mg

2-Chloro-6-fluoronicotinic acid, 95.0%, 100mg

Ethyl 5,7-dimethyl-4-oxo-1,4-dihydroquinoline-3-carboxylate, 97%, 250mg